CTRI/2024/01/061413
Not yet recruiting
未知
Evaluation of the safety and the efficacy of a novel polyherbal mouthwash containing Emblica officinalis,Cinnamomum cassia,Silicate of magnesia,Nigella sativa and Eucalyptus globulus oil in patients with gingivitis:A randomized controlled trial - NI
DR ZADC AMU ALIGARH0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: A488- Other specified bacterial diseases
- Sponsor
- DR ZADC AMU ALIGARH
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •APPARENTLY HEALTHY INDIVIDUALS WITH
- •PRESENCE OF ATLEAST 20 NATURAL TEETH
- •DIAGNOSIS OF GINGIVITIS\-DENTAL BIOFILM INDUCED
Exclusion Criteria
- •1\)PREGNANCY AND LACTATION
- •2\)DECOMPENSATED SYSTEMIC DISEASE
- •3\)DEGENERATIVE BONE DISEASE
- •4\)SJOGREN SYNDROME
- •5\)ADVANCED PERIODONTAL OR ORTHODONTIC DISEASE
- •6\)HISTORY OF ORAL PROPHYLAXIS WITHIN 6 MONTHS
- •7\)HISTORY OF TAKING ANTIBIOTICS,ANTICOAGULANT,IMMUNOSUPPRESSIVE,ANTI\-INFLAMMATORY MEDICATION OR USING ANTI\-BACTERIAL
- •MOUTH RINSES FOR PAST 6 MONTHS.
- •8\)SMOKING,DRUG AND ALCOHOL ABUSE
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the safety and effectiveness of the MID-C/ApiFix system in adolescent idiopathic scoliosis.Spinal curvature1002837710005944NL-OMON43676Vrije Universiteit Medisch Centrum33
Completed
Not Applicable
Prospective evaluation of efficacy and safety of argon plasma coagulation therapy with submucosal injection prior to ablation in Barrett's esophagusC15.5Lower third of oesophagusDRKS00003369HSK Wiesbaden60
Active, not recruiting
Not Applicable
Safety and effectiveness clinical evaluation of the range of injectable medical devices HYDRAGEL C in facial aesthetic treatmentSubjects across groups present with moderate to severe facial aesthetic concerns, including peri-oral lines, nasolabial folds, lip volume deficits, and cheeks/cheekbones volume deficit, as gauged by various dermatological scalesSkin and Connective Tissue DiseasesISRCTN13586698ouna Aesthetics75
Active, not recruiting
Not Applicable
Clinical study to evaluate the safety and effectiveness of the use of two hyaluronic acid injectable products (Perfectha® Derm Lidocaine and Perfectha® Deep Lidocaine) in the treatment of lipsFor Perfectha® Derm Lidocaine: very thin to thin lip volume and with lip contour somewhat well-defined to poorly definedfor Perfectha® Deep Lidocaine: thin to moderate lip volumeNot ApplicableISRCTN72858148Sinclair Pharma68
Not yet recruiting
Phase 4
euroEPO in mild-moderate Alzheimer's disease amnesic variantmild-moderate Alzheimer's diseaseAlzheimer DiseaseDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersRPCEC00000410Center of Molecular Immunology (CIM)1,456